Literature DB >> 19813436

Colorectal cancer testing in Canada--2008.

Kathryn Wilkins1, Margot Shields.   

Abstract

OBJECTIVES: This article provides estimates of the report level of colorectal cancer (CRC) testing in the Canadian population aged 50 or older in 2008. DATA SOURCES AND METHODS: The data are from the 2008 Canadian Community Health Survey. With weighted data, the percentage of people who had undergone CRC testing (fecal occult blood test in the past two years or endoscopy within the past five years) was estimated. Bivariate and multivariate analyses were used to examine testing status in relation to personal, socio-economic and other health-related characteristics.
RESULTS: In 2008, an estimated 40% of Canadians aged 50 or older reported that they had had CRC testing. The percentage ranged from 28% in Quebec to 53% in Manitoba. Testing was associated with being 65 or older, higher income, having a regular doctor, being a non-smoker, and being physically active.
INTERPRETATION: Organized CRC screening was limited in 2008, but may account for some of the differences in participation among the provinces.

Entities:  

Mesh:

Year:  2009        PMID: 19813436

Source DB:  PubMed          Journal:  Health Rep        ISSN: 0840-6529            Impact factor:   4.796


  18 in total

1.  Implementation of electronic medical records: effect on the provision of preventive services in a pay-for-performance environment.

Authors:  Michelle Greiver; Jan Barnsley; Richard H Glazier; Rahim Moineddin; Bart J Harvey
Journal:  Can Fam Physician       Date:  2011-10       Impact factor: 3.275

2.  Measuring Preferences for Colorectal Cancer Screening: What are the Implications for Moving Forward?

Authors:  Deborah Marshall; S Elizabeth McGregor; Gillian Currie
Journal:  Patient       Date:  2010-06-01       Impact factor: 3.883

3.  ColonCancerCheck primary care invitation pilot project: patient perceptions.

Authors:  Jill Tinmouth; Paul Ritvo; S Elizabeth McGregor; Jigisha Patel; Crissa Guglietti; Cheryl A Levitt; Lawrence F Paszat; Linda Rabeneck
Journal:  Can Fam Physician       Date:  2013-12       Impact factor: 3.275

4.  Predicting breast and colon cancer screening among English-as-a-second-language older Chinese immigrant women to Canada.

Authors:  Laura Todd; Erin Harvey; Laurie Hoffman-Goetz
Journal:  J Cancer Educ       Date:  2011-03       Impact factor: 2.037

5.  Colorectal cancer screening practices in Saskatchewan: Survey of family physicians.

Authors:  Ray Deobald; Peter Graham; Jennifer Chad; Carlo Di Gregorio; Jennifer Johnstone; Lloyd Balbuena; Chris Kenyon; Mark Lees
Journal:  Can Fam Physician       Date:  2013-12       Impact factor: 3.275

6.  Pan-Canadian initiatives in colorectal cancer screening: adopting knowledge translation tools to accelerate uptake and impact.

Authors:  H E Bryant; S V Fekete; D H Major
Journal:  Curr Oncol       Date:  2011-06       Impact factor: 3.677

7.  Trends in time to diagnosis of colon cancer and impact on clinical outcomes.

Authors:  Harminder Singh; Emma Shu; Alain Demers; Charles N Bernstein; Jane Griffith; Katherine Fradette
Journal:  Can J Gastroenterol       Date:  2012-12       Impact factor: 3.522

8.  ColonCancerCheck Primary Care Invitation Pilot project: family physician perceptions.

Authors:  Jill Tinmouth; Paul Ritvo; S Elizabeth McGregor; Criss Guglietti; Josh Green; Danielle Claus; Cheryl Levitt; Lawrence F Paszat; Linda Rabeneck
Journal:  Can Fam Physician       Date:  2012-10       Impact factor: 3.275

9.  Equity and practice issues in colorectal cancer screening: Mixed-methods study.

Authors:  Sandy Buchman; Linda Rozmovits; Richard H Glazier
Journal:  Can Fam Physician       Date:  2016-04       Impact factor: 3.275

10.  Implementing low-dose computed tomography screening for lung cancer in Canada: implications of alternative at-risk populations, screening frequency, and duration.

Authors:  W K Evans; W M Flanagan; A B Miller; J R Goffin; S Memon; N Fitzgerald; M C Wolfson
Journal:  Curr Oncol       Date:  2016-06-09       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.